PUBLISHER: The Business Research Company | PRODUCT CODE: 2112364
PUBLISHER: The Business Research Company | PRODUCT CODE: 2112364
A retractable needle syringe is a safety-focused medical injection instrument equipped with a mechanism that enables the needle to withdraw into the syringe barrel after administration, significantly reducing the possibility of accidental needle-stick injuries, contamination, and unauthorized reuse. These syringes are extensively employed in hospitals, healthcare clinics, immunization campaigns, blood sampling procedures, and home care settings because of their improved safety characteristics, infection prevention advantages, and adherence to healthcare safety standards.
The primary product categories of retractable needle syringes include automatic retractable syringes, manual retractable syringes, spring-loaded retractable syringes, auto-disable retractable syringes, and prefilled retractable syringes. Automatic retractable syringes are safety syringes equipped with an integrated mechanism that retracts the needle after use to reduce the risk of needlestick injuries. These products are manufactured using materials such as plastic, glass, and metal and are offered in low-volume, medium-volume, and high-volume capacities. They are utilized in vaccination, drug delivery, blood collection, insulin administration, and other injection procedures and are used by hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, home healthcare environments, and research and academic institutions.
Tariffs are influencing the retractable needle syringe market by increasing costs of imported medical-grade polymers, precision-engineered components, and specialized manufacturing equipment used in safety syringe production. This is elevating overall production expenses and creating supply constraints, particularly in regions dependent on imports such as Asia-Pacific and Latin America. Segments such as prefilled retractable syringes and automatic retractable syringes are most affected due to higher reliance on advanced manufacturing inputs and sterile production infrastructure. Hospitals, vaccination programs, and large-scale public health procurement systems are experiencing procurement delays and cost pressures. However, tariffs are also encouraging localized medical manufacturing, diversification of supply chains, and increased investment in domestic production capabilities, ultimately strengthening long-term healthcare supply resilience.
The retractable needle syringe market size has grown strongly in recent years. It will grow from $1.56 billion in 2025 to $1.71 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing need for infection control in healthcare settings, rising awareness of needle stick injury prevention among healthcare workers, expansion of vaccination and immunization programs globally, growing adoption of single use disposable medical devices, regulatory push for safer injection practices in hospitals and clinics.
The retractable needle syringe market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to advancement in automated and spring assisted safety syringe mechanisms, increasing demand for prefilled drug delivery systems, expansion of home healthcare and self administration treatments, rising investment in smart manufacturing of medical consumables, growing focus on hospital safety compliance and regulatory standardization. Major trends in the forecast period include rising adoption of safety engineered retractable syringe systems to reduce needle stick injuries, increasing demand for auto disable and single use syringe mechanisms in vaccination programs, growing preference for prefilled and ready to use injection formats in clinical workflows, shift toward lightweight medical grade polymer materials for cost efficiency and safety compliance, increasing integration of precision spring and locking mechanisms for controlled needle retraction.
The increasing prevalence of infectious diseases is expected to drive the growth of the retractable needle syringe market going forward. Infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals through contaminated surfaces, bodily fluids, or unsafe medical practices. The rising prevalence of infectious diseases is attributed to increasing population density and higher exposure to communicable pathogens in both healthcare and community environments. Retractable needle syringes assist in preventing infections by reducing the risk of accidental needle-stick injuries, minimizing syringe reuse, and enhancing safety during procedures such as injections, vaccinations, and blood collection. For instance, in March 2025, according to the UK Health Security Agency (UKHSA), a UK-based government agency responsible for protecting public health from infectious diseases and health threats, tuberculosis (TB) cases reported in England increased by 13% in 2024, reaching 5,480 cases compared to 4,850 cases in 2023. Therefore, the rising prevalence of infectious diseases is driving the growth of the retractable needle syringe market.
Leading companies operating in the retractable needle syringe market are focusing on technological advancements in automatic needle retraction mechanisms, such as passive safety syringe technologies, to improve healthcare worker protection, reduce needle-stick injuries, and enhance safe injection practices. Passive safety syringe technology is an automated needle protection system that retracts the needle into the syringe barrel immediately after medication delivery without requiring additional user activation, thereby improving operational safety and minimizing contamination risks. For example, in January 2026, Terumo Corporation, a Japan-based medical technology company, introduced the SurTract Safety Syringe in the United States powered by SafeR passive safety technology. The product includes automatic needle retraction immediately after injection, one-handed activation for improved usability, and an integrated safety mechanism designed to reduce accidental needle exposure and support compliance with infection-control protocols in healthcare facilities.
In March 2024, Sharps Technology, a US-based medical device and pharmaceutical packaging company, partnered with Roncadelle Operations to globally market and distribute the Securegard, SafeR, and SoloGard portfolios of disposable smart safety syringes and expand its international market reach. This collaboration extends market presence across multiple regions by combining distribution capabilities. It also speeds up the development and commercialization of safer and more advanced medical administration solutions. Roncadelle Operations is an Italy-based manufacturer of retractable needle syringes, including SafeR retractable safety syringes.
Major companies operating in the retractable needle syringe market are Becton Dickinson and Company (BD); Cardinal Health Inc.; Terumo Medical Corporation; Gerresheimer AG; West Pharmaceutical Services; Nipro Corporation; Stevanato Group S.p.A.; ICU Medical; Medtronic plc; Hindustan Syringes & Medical Devices Ltd.; McKesson Medical-Surgical Inc.; Retractable Technologies Inc.; SOL-Millennium; Vygon SA; Shanghai Kindly Enterprise Development Group Co. Ltd.; HMC Premedical S.p.A.; Changzhou Medical Appliances General Factory Co. Ltd.; MYCO Medical Supplies Inc.; DMC Medical Limited; Biolabs International LLC; Duopross Meditech Corporation.
North America was the largest region in the retractable needle syringe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retractable needle syringe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the retractable needle syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, contracts, procurement programs, or healthcare supply agreements in terms of the currency (in USD, unless otherwise specified).
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The retractable needle syringe market research report is one of a series of new reports from The Business Research Company that provides retractable needle syringe market statistics, including retractable needle syringe industry global market size, regional shares, competitors with a retractable needle syringe market share, detailed retractable needle syringe market segments, market trends and opportunities, and any further data you may need to thrive in the retractable needle syringe industry. This retractable needle syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Retractable Needle Syringe Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses retractable needle syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for retractable needle syringe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The retractable needle syringe market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.